During the past decade, University of Wisconsin Carbone Cancer Center conducted 288 clinical trials. In the 10-year time frame, 288 clinical trials started and 151 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 127 clinical trials started and 61 clinical trials were completed. i.e. 48% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Wisconsin Carbone Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 176 trials, followed by "University of Wisconsin, Madison" with 108 trials sponsored, "Children's Oncology Group" with 72 trials sponsored, "Eastern Cooperative Oncology Group" with 56 trials sponsored and "Radiation Therapy Oncology Group" with 56 trials sponsored. Other sponsors include 238 different institutions and companies that sponsored additional 116 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Wisconsin Carbone Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 339 trials as a collaborator, "NRG Oncology" with 43 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator and "Eastern Cooperative Oncology Group" with 14 trials as a collaborator. Other collaborators include 199 different institutions and companies that were collaborators in the rest 102 trials.

According to Clinical.Site data, the most researched conditions in "University of Wisconsin Carbone Cancer Center" are "Prostate Cancer" (46 trials), "Leukemia" (38 trials), "Breast Cancer" (34 trials), "Lymphoma" (32 trials) and "Brain and Central Nervous System Tumors" (31 trials). Many other conditions were trialed in "University of Wisconsin Carbone Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Wisconsin Carbone Cancer Center" are "Drug" (553 trials), "Biological" (202 trials), "Procedure" (185 trials), "Other" (181 trials) and "Radiation" (172 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "radiation therapy" (69 trials), "Computed Tomography" (54 trials), "Quality-of-Life Assessment" (53 trials) and "Biospecimen Collection" (49 trials). Other intervention names were less common.

The vast majority of trials in "University of Wisconsin Carbone Cancer Center" are 569 trials for "All" genders, 78 trials for "Female" genders and 62 trials for "Male" genders.

Currently, there are NaN active trials in "University of Wisconsin Carbone Cancer Center". 2 are not yet recruiting, 121 are recruiting, 153 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 355 completed trials in University of Wisconsin Carbone Cancer Center, 10 suspended trials, and 47 terminated clinical trials to date.

Out of the total trials that were conducted in University of Wisconsin Carbone Cancer Center, 130 "Phase 1" clinical trials were conducted, 351 "Phase 2" clinical trials and 224 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 33 trials that are defined as “Not Applicable".